jueves, 2 de noviembre de 2017

MMWR News Synopsis for November 2, 2017 | CDC Online Newsroom | CDC

MMWR News Synopsis for November 2, 2017 | CDC Online Newsroom | CDC





MMWR News Synopsis for November 3, 2017


Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014

CDC Media Relations
404-639-3286

Vaccination Coverage Among Children Aged 19–35 Months — United States, 2016

CDC Media Relations
404-639-3286

Progress in Childhood Vaccination Data in Immunization Information Systems — United States, 2013–2016

CDC Media Relations
404-639-3286

Harmful Algal Bloom–Associated Illnesses in Humans and Dogs Identified Through a Pilot Surveillance System — New York, 2015

Gary Holmes
New York State Health Department
518-402-7650

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017

CDC Media Relations
404-639-3286


Implementation of Rotavirus Surveillance and Vaccine Introduction — World Health Organization African Region Countries, 2007–2016

CDC Media Relations
404-639-3286

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014

CDC Media Relations
404-639-3286
Most people with kidney disease are unaware of their condition. Diabetes and high blood pressure are major risk factors for kidney disease and kidney failure. Early detection and better management of kidney disease in people with diabetes can slow progression to kidney failure and improve health outcomes. In adults with diabetes, effective interventions to improve blood sugar and blood pressure control might prevent or delay the onset of kidney disease. Kidney failure treated with dialysis or a kidney transplant is called end-stage renal disease (ESRD). ESRD is a costly and disabling condition often resulting in premature death. However, during 2000–2014, kidney failure from diabetes among U.S. adults with diabetes decreased by 33 percent, and it declined significantly in most states, the District of Columbia, and Puerto Rico. No state experienced an increase in kidney failure from diabetes. Continued awareness and interventions to reduce risk factors for kidney failure, improve diabetes care, and prevent type 2 diabetes might sustain these positive trends.

Vaccination Coverage Among Children Aged 19–35 Months — United States, 2016

CDC Media Relations
404-639-3286
CDC encourages parents to protect their children from vaccine-preventable diseases by ensuring their children receive all recommended vaccines on schedule. Vaccination is the best way to reduce illness and death from vaccine-preventable diseases in young children. Data from the 2016 National Immunization Survey-Child (NIS-Child) were used to assess vaccination coverage with recommended vaccines among children aged 19–35 months in the United States. Based on the data, coverage with recommended vaccines for children aged 19–35 months continues to be high and stable, but remains below 90 percent for vaccines that require booster doses during the second year of life and for more recently recommended vaccines. Differences in coverage by race/ethnicity, poverty status, and insurance status indicate that improvements are needed in the immunization safety net (that is, access to and delivery of age-appropriate immunization to all children, regardless of insurance or financial status).

Progress in Childhood Vaccination Data in Immunization Information Systems — United States, 2013–2016

CDC Media Relations
404-639-3286
Incremental progress in four Immunization Information System (IIS) priority areas was noted since 2013, but continued effort is needed to implement these critical functionalities among all IISs. IISs are computerized, population-based systems that consolidate vaccination data from providers for clinical and public health use. Data from 2013–2016 were analyzed to assess progress made in four priority areas: 1) pediatric data completeness, 2) bidirectional data exchange with electronic health records, 3) pediatric clinical decision support for immunizations, and 4) ability to generate jurisdictional and provider-level vaccination coverage estimates. Progress was noted since 2013, but continued effort is needed to implement these functionalities among all IISs. Success in these priority areas bolsters public health practitioners’ ability to attain high childhood vaccination coverage and prepares IISs to develop more advanced functionalities. Success also supports the achievement of federal immunization objectives, including using IISs as supplemental sampling frames for vaccination coverage surveys.

No hay comentarios: